Ex vivo renal artery reconstruction is an extensive procedure used to treat complex aneurysms of the artery that supplies your kidney. It involves removing your kidney, repairing the artery, and ...

A renal allograft recipient (underlying disease IgA nephropathy) went into renal failure 10 days after transplantation. The donor kidney had multiple cortical cysts and 2 separate renal arteries. A ...

The renal arteries typically arise from the lateral aspects of the abdominal aorta at the level of the first lumbar vertebra, each entering the hilum of its respective kidney. Upon approach to the ...

AS A result of Goldblatt's studies on experimental hypertension, reported in 1937, 1 there has been a revival of interest and investigation in renal-artery occlusion as a cause of hypertension in man.

Ablating the sympathetic nerves in accessory renal arteries might help enhance the blood pressure-lowering effects of renal denervation, a study of tissues from human cadavers suggests. Though ...

THE appreciation of renal-artery lesions as a cause of systemic hypertension began with the work of Goldblatt et al. 1 in 1934. This experimental finding was immediately implicated in human ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Doctors in the U.K. have announced a rare medical case where an organ ...

Barcelona, Spain – Sunday 31 August 2014: Renal denervation seems to be more successful at reducing blood pressure in patients with resistant hypertension when it includes accessory renal arteries, ...

SAN DIEGO, CA—Concordant with studies of other technologies for renal denervation, the presence of untreated accessory arteries was associated with a reduced blood pressure-lowering response to the ...

VANCOUVER, British Columbia—Transplantation of kidneys with single or multiple arteries results in similar long-term outcomes, according to new study presented at The Transplantation Society’s 2010 ...

The treatment of resistant hypertension has received a boost with the recent US Food and Drug Administration (FDA) approval of a completely new therapeutic approach that reduces activity in the ...